Literature DB >> 12401705

Effects of insulin deficiency or excess on hepatic gluconeogenic flux during glycogenolytic inhibition in the conscious dog.

Dale S Edgerton1, Sylvain Cardin, Catherine Pan, Doss Neal, Ben Farmer, Margaret Converse, Alan D Cherrington.   

Abstract

The direct acute effects of insulin on the regulation of hepatic gluconeogenic flux to glucose-6-phosphate (G6P) in vivo may be masked by the hormone's effects on net hepatic glycogenolytic flux and the resulting changes in glycolysis. To investigate this possibility, we used a glycogen phosphorylase inhibitor (BAY R3401) to inhibit glycogen breakdown in the overnight-fasted dog, and the effects of complete insulin deficiency or a fourfold rise in the plasma insulin level were assessed during a 5-h experimental period. Hormone levels were controlled using somatostatin with portal insulin and glucagon infusion. After the control period, plasma insulin infusion 1) was discontinued, creating insulin deficiency; 2) increased fourfold; or 3) was continued at the basal rate. During insulin deficiency, glucose production and the plasma level and net hepatic uptake of nonesterified free fatty acids increased, whereas during hyperinsulinemia they decreased. Net hepatic lactate uptake increased sixfold during insulin deficiency and 2.5-fold during hyperinsulinemia. Net hepatic gluconeogenic flux increased more than fourfold during insulin deficiency but was not reduced by hyperinsulinemia. We conclude that in the absence of appreciable glycogen breakdown, an acute gluconeogenic effect of hypoinsulinemia becomes manifest, whereas inhibition of the process by a physiologic rise in insulin was not evident.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401705     DOI: 10.2337/diabetes.51.11.3151

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo.

Authors:  Christopher J Ramnanan; Dale S Edgerton; Noelia Rivera; Jose Irimia-Dominguez; Ben Farmer; Doss W Neal; Margaret Lautz; E Patrick Donahue; Catalina M Meyer; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

2.  Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs.

Authors:  Justin M Gregory; Margaret Lautz; Lindsey M Moore; Phillip E Williams; Praveen Reddy; Alan D Cherrington
Journal:  Diabetes Obes Metab       Date:  2018-09-16       Impact factor: 6.577

3.  Peripherally delivered hepatopreferential insulin analog insulin-406 mimics the hypoglycaemia-sparing effect of portal vein human insulin infusion in dogs.

Authors:  Justin M Gregory; Guillaume Kraft; Melanie F Scott; Doss W Neal; Ben Farmer; Marta S Smith; Jon R Hastings; Peter Madsen; Thomas B Kjeldsen; Susanne Hostrup; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  Diabetes Obes Metab       Date:  2019-07-08       Impact factor: 6.577

4.  Comparison of insulins detemir and glargine: effects on glucose disposal, hepatic glucose release and the central nervous system.

Authors:  M C Moore; M S Smith; M K Turney; S Boysen; P E Williams
Journal:  Diabetes Obes Metab       Date:  2011-09       Impact factor: 6.577

5.  Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes.

Authors:  Justin M Gregory; Guillaume Kraft; Melanie F Scott; Doss W Neal; Ben Farmer; Marta S Smith; Jon R Hastings; Eric J Allen; E Patrick Donahue; Noelia Rivera; Jason J Winnick; Dale S Edgerton; Erica Nishimura; Christian Fledelius; Christian L Brand; Alan D Cherrington
Journal:  Diabetes       Date:  2015-06-17       Impact factor: 9.461

6.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

7.  The kinetics of glucagon action on the liver during insulin-induced hypoglycemia.

Authors:  Christina Pedersen; Guillaume Kraft; Dale S Edgerton; Melanie Scott; Ben Farmer; Marta Smith; David C Laneve; Phillip E Williams; L Merkle Moore; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-03-24       Impact factor: 4.310

8.  Four weeks exercise training enhanced the hepatic insulin sensitivity in high fat- and high carbohydrate-diet fed hyperinsulinemic rats.

Authors:  Anu Joseph; S Parvathy; Koyikkal Karthikeya Varma; Aiswarya Nandakumar
Journal:  J Diabetes Metab Disord       Date:  2020-11-25

9.  Pharmacokinetics and Pharmacodynamics of Insulin Tregopil in Relation to Premeal Dosing Time, Between Meal Interval, and Meal Composition in Patients With Type 2 Diabetes Mellitus.

Authors:  Anand Khedkar; Harold Lebovitz; Alexander Fleming; Alan Cherrington; Vinu Jose; Sandeep N Athalye; Ashwini Vishweswaramurthy
Journal:  Clin Pharmacol Drug Dev       Date:  2019-08-07

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.